Clinical trial Recruiting at 1 site Observational Ages 3 to 12

How obstructive sleep apnea affects thinking and empathy in children

Official title: Observational Study on the Impact of Obstructive Sleep Apnea on Executive Function and Empathy Development in Children

Run by Children's Hospital of Soochow University · NCT06850220 · Data updated 2026-11-12

This project will see if obstructive sleep apnea and different treatments affect thinking skills and empathy in children aged 3–12 and whether EEG signals can serve as biomarkers.

Quick facts

Study typeObservational
Ages3 Years to 12 Years
SexAll
Enrollment150 (estimated)
SponsorChildren's Hospital of Soochow University
Academic / other
Locations1 site (Suzhou, Jiangsu)
StatusRecruiting
StartedOctober 13, 2025
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedJanuary 26, 2026
Trial IDNCT06850220 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 3–12 with OSA due to adenoid and/or tonsillar hypertrophy, IQ ≥ 85, and whose parents provide consent.

Probably not a fit

Children with other primary sleep disorders, developmental delay, epilepsy, significant chronic illness, prior head trauma, or those outside the 3–12 age range are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational cohort at the Children's Hospital of Soochow University follows children aged 3–12 with OSA caused by adenoid and/or tonsillar hypertrophy. Participants are grouped by disease severity (mild, moderate, severe) and by treatment choice (surgical or pharmacological) and are assessed at baseline, 6 months, and 12 months. Outcomes include behavioral tests of executive function and empathy, parent-reported questionnaires, and EEG recordings to explore potential biomarkers of neurological injury. The goal is to inform treatment decisions for mild OSA and identify EEG patterns linked to cognitive or emotional changes.

Why it matters

Potential benefit: If successful, the findings could help clinicians choose better treatments for mild pediatric OSA and detect early brain changes using EEG biomarkers.

How similar studies have gone: Prior research has linked pediatric OSA to cognitive and behavioral problems and shown EEG differences, but using EEG biomarkers to guide treatment remains preliminary.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children aged 3-12 years.
* Diagnosed with OSA due to adenoid and/or tonsillar hypertrophy.
* IQ ≥ 85.
* Parental consent for participation.

Exclusion Criteria:

* Other primary sleep disorders (e.g., narcolepsy, restless leg syndrome).
* Developmental delay, epilepsy, or other neurological/metabolic disorders.
* Chronic diseases or history of head trauma.

Where it's running

  • Children's Hospital of Soochow University
    Suzhou, Jiangsu, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.